# Mundipharma Research Limited clinical trials: 36 (2026)

ClinicalTrials.gov lists 36 trials with Mundipharma Research Limited as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Mundipharma Research Limited: 36 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/mundipharma-research-limited

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 36
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 36, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 27, 2025 | NCT06794554 | Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options | Mundipharma Research Limited | Phase 2 | Active not recruiting | Chronic Pulmonary Aspergillosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06794554) |
| April 28, 2023 | NCT05835479 | Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults | Mundipharma Research Limited | Phase 2 | Recruiting | Pneumocystis Pneumonia | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05835479) |
| September 9, 2022 | NCT05534529 | Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to \<18 Years of Age | Mundipharma Research Limited | Phase 1 | Terminated | Invasive Fungal Infections | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05534529) |
| June 27, 2022 | NCT05432375 | Study of Tinostamustine for Adjuvant Treatment of Glioblastoma | Mundipharma Research Limited | Early phase 1 | Completed | Glioblastoma Multiforme | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05432375) |
| April 30, 2020 | NCT04368559 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic... | Mundipharma Research Limited | Phase 3 | Completed | Candidemia, Mycoses, Fungal Infection, Fungemia, Invasive Candidiasis, Pneumocystis, Mold Infection, Invasive Fungal... | 602 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04368559) |
| November 17, 2017 | NCT03345485 | Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. | Mundipharma Research Limited | Phase 1/2 | Completed | Small Cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer, Ovarian Cancer, Endometrial Cancer | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03345485) |
| May 16, 2016 | NCT02773316 | Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral... | Mundipharma Research Limited | Phase 1 | Completed | Opioid Substitution Treatment | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02773316) |
| April 28, 2016 | NCT02753712 | A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity... | Mundipharma Research Limited | Phase 3 | Completed | Asthma | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02753712) |
| February 29, 2016 | NCT02693769 | A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and... | Mundipharma Research Limited | Phase 2/3 | Terminated | ACOS (Fixed Airflow Obstruction and Elevated Eosinophils) | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02693769) |
| October 15, 2015 | NCT02576496 | Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies | Mundipharma Research Limited | Phase 1 | Completed | Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma, Cutaneous T Cell Lymphoma | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02576496) |
| May 18, 2015 | NCT02446561 | A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication | Mundipharma Research Limited | Phase 1 | Completed | Pain | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02446561) |
| May 1, 2015 | NCT02431624 | An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion | Mundipharma Research Limited | Phase 1 | Completed | Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02431624) |
| March 31, 2015 | NCT02403713 | A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers | Mundipharma Research Limited | Phase 1 | Completed | Asthma | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02403713) |
| October 20, 2014 | NCT02268422 | Bioequivalence and Adhesion Comparison of Buprenorphine Patches | Mundipharma Research Limited | Phase 1 | Completed | Pain | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02268422) |
| July 21, 2014 | NCT02195375 | Flutiform® Compared With Seretide® in the Treatment of COPD | Mundipharma Research Limited | Phase 2/3 | Completed | Chronic Obstructive Pulmonary Disease | 923 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02195375) |
| June 10, 2014 | NCT02160067 | A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches | Mundipharma Research Limited | Phase 1 | Completed | Pain | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02160067) |
| May 8, 2014 | NCT02133820 | A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong... | Mundipharma Research Limited | Phase 1 | Completed | Pain | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02133820) |
| March 18, 2014 | NCT02089581 | A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication | Mundipharma Research Limited | Phase 1 | Completed | Pain | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02089581) |
| February 14, 2014 | NCT02063139 | Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged... | Mundipharma Research Limited | Phase 2 | Completed | Mild Persistent Asthma | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02063139) |
| September 19, 2013 | NCT01946620 | A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD | Mundipharma Research Limited | Phase 3 | Completed | Chronic Obstructive Pulmonary Disease | 1,767 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01946620) |
| March 29, 2013 | NCT01821040 | A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR | Mundipharma Research Limited | Phase 3 | Terminated | Polymyalgia Rheumatica | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01821040) |
| December 3, 2012 | NCT01739387 | A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI) | Mundipharma Research Limited | Observational | Completed | Asthma, COPD | 332 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01739387) |
| January 18, 2012 | NCT01511367 | Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients | Mundipharma Research Limited | Phase 3 | Completed | Asthma | 498 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01511367) |
| February 3, 2011 | NCT01289223 | A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. | Mundipharma Research Limited | Phase 3 | Terminated | Indolent B-cell NHL | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01289223) |
| October 21, 2010 | NCT01225861 | Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK | Mundipharma Research Limited | Observational | Completed | Chronic Pain | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01225861) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 12 |
| Phase 1/2 | 3 |
| Phase 2 | 4 |
| Phase 2/3 | 2 |
| Phase 3 | 12 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 26 |
| Terminated | 8 |
| Recruiting | 1 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Asthma | 9 |
| Pain | 6 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Pneumonia, Pneumocystis | 2 |
| Recurrence | 2 |
| Invasive Fungal Infections | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia | 1 |
| Brain Neoplasms | 1 |
| Meningeal Carcinomatosis | 1 |
| Cancer Pain | 1 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Lymphoma, T-Cell | 1 |
| Polymyalgia Rheumatica | 1 |
| Glioblastoma | 1 |
| Small Cell Lung Carcinoma | 1 |
| Sarcoma | 1 |
| Triple Negative Breast Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Fallopian Tube Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Chronic Pain | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Threads and yarns wholesalers in the United States](https://specstream.ai/data/businesses/threads-and-yarns-wholesalers/united-states)
- [Pediatric surgery practices in the United States](https://specstream.ai/data/businesses/pediatric-surgery-practices/united-states)
- [Indo Chinese restaurants in the United States](https://specstream.ai/data/businesses/indo-chinese-restaurants/united-states)
- [Doner kebab restaurants in the United States](https://specstream.ai/data/businesses/doner-kebab-restaurants/united-states)
- [B2B oil and gas exploration and development companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-exploration-and-development-companies/united-states)
- [Taiwanese restaurants in the United States](https://specstream.ai/data/businesses/taiwanese-restaurants/united-states)
